S. Ibraheem Mahmood of AMO Pharma: “Listen hard to ideas around you then be decisive”
Listen hard to ideas around you then be decisive: Our clinical program AMO-06, in development for treatment of combat related PTSD, is a highly unusual and difficult disease target, but listening to our chief scientific and chief medical executives, whose knowledge of the area is extensive, made it seem like a no brainer that we…